Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Marriott Wardman Park Hotel

27 ene 2020 7:00 a.m. - 29 ene 2020 4:15 p.m.

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Featured

Want to learn more about Pharmacovigilance and Risk Management Strategies Conference? You've come to the right site!

Continuing Education

Highlights & Features

Short Course or Primer

To keep you at the forefront.

26 ene 2020

Short Course 1:

Pharmacovigilance and Risk Management Planning

26 ene 2020

Short Course 2:

Interdisciplinary Safety Evaluation During Product Development

26 ene 2020

Short Course 3:

Reference Safety Information

26 ene 2020

Short Course 4:

Introduction to Statistics in Pharmacovigilance

26 ene 2020

Short Course 5:

Pharmacovigilance for Medication Errors

Comité del programa

  • Stella  Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
    Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP Strategy
    Consultant, United Kingdom
  • William  Gregory, PhD
    William Gregory, PhD Senior Director, Safety and Risk Management
    Pfizer Inc, United States
  • Catherine  Baldridge, MSc
    Catherine Baldridge, MSc Head of Safety
    Fusion Pharmaceuticals, United States
  • Mariette  Boerstoel-Streefland, MD, MBA, MS
    Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Worldwide Safety Officer
    Bristol-Myers Squibb Company, United States
  • Cheryl  Campbell, MS
    Cheryl Campbell, MS Associate Director of Executive Operations/Outreach and Communications, OSE,CDER
    FDA, United States
  • Ingrid N. Chapman, PharmD
    Ingrid N. Chapman, PharmD Senior Risk Management Analyst, DRM, OMEPRM, OSE, CDER
    FDA, United States
  • Mick  Foy
    Mick Foy Director of Delivery
    Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
  • E. Stewart  Geary, MD
    E. Stewart Geary, MD MD, Global Safety Officer
    Eisai Co., Ltd., Japan
  • Stephen  Knowles, MD, MRCP
    Stephen Knowles, MD, MRCP Chief Medical Officer
    Halozyme Therapeutics, United States
  • Jill K. Logan, PharmD
    Jill K. Logan, PharmD Safety Evaluator, DPV I, OSE, CDER
    FDA, United States
  • Barbara  Morollo, RN
    Barbara Morollo, RN Head, Pharmacovigilance
    Corbus Pharmaceuticals, United States
  • Michael  Richardson, MD, FFPM, FRCP
    Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
    Bristol-Myers Squibb, United Kingdom
  • Annette  Stemhagen, DrPH, PhD, FISPE
    Annette Stemhagen, DrPH, PhD, FISPE Chief Science Officer
    UBC, United States
  • Lesley  Wise, PhD, MSc
    Lesley Wise, PhD, MSc Managing Director
    Wise Pharmacovigilance and Risk Management, Ltd, United Kingdom
  • Hui-Lee  Wong, PhD, MS
    Hui-Lee Wong, PhD, MS Epidemiologist, Sentinel Central Team, OBE, CBER
    FDA, United States
  • Jo  Wyeth, PharmD
    Jo Wyeth, PharmD Associate Director for Postmarket Assessments, OMEPRM, OSE, CDER
    FDA, United States

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.